Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Schizophrenia
Interventions
DRUG

Quetiapine Fumarate XR

oral, once daily, flexible dose

Trial Locations (7)

Unknown

Research site, Ansan

Research site, Gwangju

Research site, Bugok

Research site, Masan

Research site, Incheon

Research site, Pusan

Research site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY